Role of Histone Deacetylases in Carcinogenesis: Potential Role in Cholangiocarcinoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of Histone Deacetylases in Carcinogenesis: Potential Role in Cholangiocarcinoma
Authors
Keywords
-
Journal
Cells
Volume 9, Issue 3, Pages 780
Publisher
MDPI AG
Online
2020-03-25
DOI
10.3390/cells9030780
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Primary cilia and their role in cancer (Review)
- (2019) Michael Higgins et al. Oncology Letters
- Zinc-dependent deacetylase (HDAC) inhibitors with different ZBG groups
- (2019) Yan Li et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- The SIRT2/cMYC Pathway Inhibits Peroxidation-Related Apoptosis In Cholangiocarcinoma Through Metabolic Reprogramming
- (2019) Lei Xu et al. NEOPLASIA
- Combination of a Histone Deacetylase 6 Inhibitor and a Somatostatin Receptor Agonist Synergistically Reduces Hepatorenal Cystogenesis in an Animal Model of Polycystic Liver Disease
- (2018) Maria Lorenzo Pisarello et al. AMERICAN JOURNAL OF PATHOLOGY
- The cholangiocyte primary cilium in health and disease
- (2018) Adrian P. Mansini et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Peanut testa extracts possessing histone deacetylase inhibitory activity induce apoptosis in cholangiocarcinoma cells
- (2018) Somprasong Saenglee et al. BIOMEDICINE & PHARMACOTHERAPY
- MicroRNA (miR)-433 and miR-22 dysregulations induce histone-deacetylase-6 overexpression and ciliary loss in cholangiocarcinoma
- (2018) Adrian P. Mansini et al. HEPATOLOGY
- Targeting Histone Deacetylases with Natural and Synthetic Agents: An Emerging Anticancer Strategy
- (2018) Amit Singh et al. Nutrients
- Beyond histone acetylation—writing and erasing histone acylations
- (2018) Shuai Zhao et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- An overview of Sirtuins as potential therapeutic target: Structure, function and modulators
- (2018) Yijie Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- The chemosensory function of primary cilia regulates cholangiocyte migration, invasion and tumor growth
- (2018) Adrian P. Mansini et al. HEPATOLOGY
- Butyrate inhibits HBV replication and HBV-induced hepatoma cell proliferation via modulating SIRT-1/Ac-p53 regulatory axis
- (2018) Kishor Pant et al. MOLECULAR CARCINOGENESIS
- Primary Cilia as Signaling Hubs in Health and Disease
- (2018) Yuhei Nishimura et al. Advanced Science
- Histone Deacetylase Inhibitor-Induced Autophagy in Tumor Cells: Implications for p53
- (2017) Maria Mrakovcic et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Histone Deacetylase Inhibitors as Anticancer Drugs
- (2017) Tomas Eckschlager et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Epithelial-mesenchymal transition in cholangiocarcinoma: From clinical evidence to regulatory networks
- (2017) Javier Vaquero et al. JOURNAL OF HEPATOLOGY
- Cholangiocarcinoma — evolving concepts and therapeutic strategies
- (2017) Sumera Rizvi et al. Nature Reviews Clinical Oncology
- Histone deacetylase 3 overexpression in human cholangiocarcinoma and promotion of cell growth via apoptosis inhibition
- (2017) Yuyao Yin et al. Cell Death & Disease
- Butyrate induces ROS-mediated apoptosis by modulating miR-22/SIRT-1 pathway in hepatic cancer cells
- (2017) Kishor Pant et al. Redox Biology
- CG200745, an HDAC inhibitor, induces anti-tumour effects in cholangiocarcinoma cell lines via miRNAs targeting the Hippo pathway
- (2017) Dawoon E. Jung et al. Scientific Reports
- Sirtuins, Cell Senescence, and Vascular Aging
- (2016) Yujiro Kida et al. CANADIAN JOURNAL OF CARDIOLOGY
- HDAC2 promotes loss of primary cilia in pancreatic ductal adenocarcinoma
- (2016) Tetsuo Kobayashi et al. EMBO REPORTS
- Identification of drugs that restore primary cilium expression in cancer cells
- (2016) Niamat Ali Khan et al. Oncotarget
- New Insights into the Connection Between Histone Deacetylases, Cell Metabolism, and Cancer
- (2015) Ferdinando Chiaradonna et al. ANTIOXIDANTS & REDOX SIGNALING
- The chemical biology of sirtuins
- (2015) Bing Chen et al. CHEMICAL SOCIETY REVIEWS
- MPP8 and SIRT1 crosstalk in E-cadherin gene silencing and epithelial-mesenchymal transition
- (2015) L. Sun et al. EMBO REPORTS
- Synergistic anticancer effects of cisplatin and histone deacetylase inhibitors (SAHA and TSA) on cholangiocarcinoma cell lines
- (2015) MD. ALI ASGAR et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Histone Deacetylase 10 Regulates the Cell Cycle G2/M Phase Transition via a Novel Let-7–HMGA2–Cyclin A2 Pathway
- (2015) Yixuan Li et al. MOLECULAR AND CELLULAR BIOLOGY
- (−)-Epigallocatechin-3-gallate reverses the expression of various tumor-suppressor genes by inhibiting DNA methyltransferases and histone deacetylases in human cervical cancer cells
- (2015) MUNAWWAR ALI KHAN et al. ONCOLOGY REPORTS
- Deacetylation of α-tubulin and cortactin is required for HDAC6 to trigger ciliary disassembly
- (2015) Jie Ran et al. Scientific Reports
- HDAC Family Members Intertwined in the Regulation of Autophagy: A Druggable Vulnerability in Aggressive Tumor Entities
- (2015) Emily Koeneke et al. Cells
- Histone Deacetylase Inhibitors Inhibit the Proliferation of Gallbladder Carcinoma Cells by Suppressing AKT/mTOR Signaling
- (2015) Peng Zhang et al. PLoS One
- Eradication of metastatic melanoma through cooperative expression of RNA-based HDAC1 inhibitor and p73 by oncolytic adenovirus
- (2015) Holger Schipper et al. Oncotarget
- HDAC6 Is Overexpressed in Cystic Cholangiocytes and Its Inhibition Reduces Cystogenesis
- (2014) Sergio A. Gradilone et al. AMERICAN JOURNAL OF PATHOLOGY
- (−)-Epigallocatechin-3-gallate induces cancer cell apoptosis via acetylation of amyloid precursor protein
- (2014) Qian Hu et al. MEDICAL ONCOLOGY
- Histone deacetylase inhibitor-mediated cell death is distinct from its global effect on chromatin
- (2014) Victoria L. Luchenko et al. Molecular Oncology
- Histone Deacetylase HDAC4 Promotes Gastric Cancer SGC-7901 Cells Progression via p21 Repression
- (2014) Zhen-Hua Kang et al. PLoS One
- Cholangiocarcinoma: Molecular Pathways and Therapeutic Opportunities
- (2014) Sumera Rizvi et al. SEMINARS IN LIVER DISEASE
- Erasers of Histone Acetylation: The Histone Deacetylase Enzymes
- (2014) E. Seto et al. Cold Spring Harbor Perspectives in Biology
- A Gnotobiotic Mouse Model Demonstrates That Dietary Fiber Protects against Colorectal Tumorigenesis in a Microbiota- and Butyrate-Dependent Manner
- (2014) D. R. Donohoe et al. Cancer Discovery
- The Role of Dietary Histone Deacetylases (HDACs) Inhibitors in Health and Disease
- (2014) Shalome Bassett et al. Nutrients
- Histone Deacetylases and their Inhibitors as Potential Therapeutic Drugs for cholangiocarcinoma - Cell Line findings
- (2013) Ruethairat Sriraksa et al. Asian Pacific Journal of Cancer Prevention
- HDAC6 Inhibition Restores Ciliary Expression and Decreases Tumor Growth
- (2013) S. A. Gradilone et al. CANCER RESEARCH
- Anticancer effects of sodium butyrate on hepatocellular carcinoma cells in vitro
- (2013) HONG-GANG WANG et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Histone deacetylase 6–mediated selective autophagy regulates COPD-associated cilia dysfunction
- (2013) Hilaire C. Lam et al. JOURNAL OF CLINICAL INVESTIGATION
- HDAC5 is required for maintenance of pericentric heterochromatin and controls cell-cycle progression and survival of human cancer cells
- (2012) P Peixoto et al. CELL DEATH AND DIFFERENTIATION
- Stimulation of Histone Deacetylase Activity by Metabolites of Intermediary Metabolism
- (2012) Maria Vogelauer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- HDAC2 overexpression confers oncogenic potential to human lung cancer cells by deregulating expression of apoptosis and cell cycle proteins
- (2012) Kwang Hwa Jung et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- The therapeutic effect of histone deacetylase inhibitor PCI-24781 on gallbladder carcinoma in BK5.erbB2 mice
- (2012) Takuya Kitamura et al. JOURNAL OF HEPATOLOGY
- Histone deacetylase 3 inhibits expression of PUMA in gastric cancer cells
- (2012) Lifeng Feng et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Targeted Inactivation of HDAC2 Restores p16INK4a Activity and Exerts Antitumor Effects on Human Gastric Cancer
- (2012) J. K. Kim et al. MOLECULAR CANCER RESEARCH
- The Warburg Effect Dictates the Mechanism of Butyrate-Mediated Histone Acetylation and Cell Proliferation
- (2012) Dallas R. Donohoe et al. MOLECULAR CELL
- Histone Acetylation Regulates Intracellular pH
- (2012) Matthew A. McBrian et al. MOLECULAR CELL
- Lactate, a product of glycolytic metabolism, inhibits histone deacetylase activity and promotes changes in gene expression
- (2012) Tom Latham et al. NUCLEIC ACIDS RESEARCH
- SIRT1 induces EMT by cooperating with EMT transcription factors and enhances prostate cancer cell migration and metastasis
- (2012) V Byles et al. ONCOGENE
- L-Carnitine Is an Endogenous HDAC Inhibitor Selectively Inhibiting Cancer Cell Growth In Vivo and In Vitro
- (2012) Hongbiao Huang et al. PLoS One
- Histone deacetylases 1 and 2 regulate autophagy flux and skeletal muscle homeostasis in mice
- (2012) V. Moresi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Suppression of Oxidative Stress by -Hydroxybutyrate, an Endogenous Histone Deacetylase Inhibitor
- (2012) T. Shimazu et al. SCIENCE
- Sirtuins and Disease: The Road Ahead
- (2012) Vincenzo Carafa et al. Frontiers in Pharmacology
- Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer
- (2011) Ali Aghdassi et al. GUT
- EZH2 supports nasopharyngeal carcinoma cell aggressiveness by forming a co-repressor complex with HDAC1/HDAC2 and Snail to inhibit E-cadherin
- (2011) Z-T Tong et al. ONCOGENE
- Energy Metabolism in H460 Lung Cancer Cells: Effects of Histone Deacetylase Inhibitors
- (2011) Nívea Dias Amoêdo et al. PLoS One
- p53 post-translational modification: deregulated in tumorigenesis
- (2010) Chao Dai et al. TRENDS IN MOLECULAR MEDICINE
- Histone deacetylase inhibitor (SAHA) and repression of EZH2 synergistically inhibit proliferation of gallbladder carcinoma
- (2009) Junpei Yamaguchi et al. CANCER SCIENCE
- E-Cadherin Regulates Metastasis of Pancreatic Cancer In Vivo and Is Suppressed by a SNAIL/HDAC1/HDAC2 Repressor Complex
- (2009) Johannes von Burstin et al. GASTROENTEROLOGY
- Regulation of Histone Acetylation in the Nucleus by Sphingosine-1-Phosphate
- (2009) N. C. Hait et al. SCIENCE
- Dietary Manipulation of Histone Structure and Function
- (2008) Barbara Delage et al. Annual Review of Nutrition
- Colon cancer cells maintain low levels of pyruvate to avoid cell death caused by inhibition of HDAC1/HDAC3
- (2008) Muthusamy Thangaraju et al. BIOCHEMICAL JOURNAL
- Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and treatment
- (2008) Boris Blechacz et al. HEPATOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started